VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 44 filers reported holding VINCERX PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $143,000 | -67.1% | 108,459 | 0.0% | 0.01% | -42.9% |
Q1 2022 | $434,000 | -60.6% | 108,459 | +0.3% | 0.01% | -65.0% |
Q4 2021 | $1,102,000 | +14.0% | 108,159 | +80.8% | 0.04% | +37.9% |
Q3 2021 | $967,000 | -65.2% | 59,809 | -72.1% | 0.03% | -66.7% |
Q2 2021 | $2,780,000 | -3.7% | 214,033 | +43.2% | 0.09% | +6.1% |
Q1 2021 | $2,886,000 | -4.2% | 149,516 | +3.8% | 0.08% | -24.8% |
Q4 2020 | $3,011,000 | – | 144,015 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAGE RHINO CAPITAL LLC | 1,618,199 | $6,473,000 | 1.96% |
Affinity Asset Advisors, LLC | 1,374,098 | $5,496,000 | 0.88% |
TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $4,123,000 | 0.82% |
SPHERA FUNDS MANAGEMENT LTD. | 720,161 | $2,881,000 | 0.41% |
Rubric Capital Management LP | 2,107,000 | $8,428,000 | 0.30% |
Long Focus Capital Management, LLC | 430,200 | $1,721,000 | 0.22% |
SABBY MANAGEMENT, LLC | 327,236 | $1,309,000 | 0.20% |
Clearline Capital LP | 412,657 | $1,651,000 | 0.19% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $1,540,000 | 0.16% |
Sio Capital Management, LLC | 102,049 | $408,000 | 0.14% |